These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 11876585)

  • 21. Pilot study of once-daily simplification therapy with abacavir/lamivudine/zidovudine and efavirenz for treatment of HIV-1 infection.
    Ruane P; Lang J; DeJesus E; Berger DS; Dretler R; Rodriguez A; Ward DJ; Lim ML; Liao Q; Reddy S; Clair MS; Vila T; Shaefer MS
    HIV Clin Trials; 2006; 7(5):229-36. PubMed ID: 17162316
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dolutegravir does not affect methadone pharmacokinetics in opioid-dependent, HIV-seronegative subjects.
    Song I; Mark S; Chen S; Savina P; Wajima T; Peppercorn A; Bala U; Geoffroy P; Piscitelli S
    Drug Alcohol Depend; 2013 Dec; 133(2):781-4. PubMed ID: 24018316
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of lersivirine co-administration on pharmacokinetics of methadone in healthy volunteers.
    Vourvahis M; Wang R; Gruener DM; Bruce RD; Haider S; Tawadrous M
    Drug Alcohol Depend; 2012 Nov; 126(1-2):183-8. PubMed ID: 22682979
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolism and pharmacokinetics of the combination Zidovudine plus Lamivudine in the adult Erythrocebus patas monkey determined by liquid chromatography-tandem mass spectrometric analysis.
    Divi RL; Doerge DR; Twaddle NC; Shockley ME; St Claire MC; Harbaugh JW; Harbaugh SW; Poirier MC
    Toxicol Appl Pharmacol; 2008 Jan; 226(2):206-11. PubMed ID: 17949768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. AVANTI 3: a randomized, double-blind trial to compare the efficacy and safety of lamivudine plus zidovudine versus lamivudine plus zidovudine plus nelfinavir in HIV-1-infected antiretroviral-naive patients.
    Gartland M;
    Antivir Ther; 2001 Jun; 6(2):127-34. PubMed ID: 11491417
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of tenofovir disoproxil fumarate on the pharmacokinetics and pharmacodynamics of total, R-, and S-methadone.
    Smith PF; Kearney BP; Liaw S; Cloen D; Bullock JM; Haas CE; Yale K; Booker BM; Berenson CS; Coakley DF; Flaherty JF
    Pharmacotherapy; 2004 Aug; 24(8):970-7. PubMed ID: 15338845
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized trial of three maintenance regimens given after three months of induction therapy with zidovudine, lamivudine, and indinavir in previously untreated HIV-1-infected patients. Trilège (Agence Nationale de Recherches sur le SIDA 072) Study Team.
    Pialoux G; Raffi F; Brun-Vezinet F; Meiffrédy V; Flandre P; Gastaut JA; Dellamonica P; Yeni P; Delfraissy JF; Aboulker JP
    N Engl J Med; 1998 Oct; 339(18):1269-76. PubMed ID: 9791142
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of oral ganciclovir alone and in combination with zidovudine, didanosine, and probenecid in HIV-infected subjects.
    Cimoch PJ; Lavelle J; Pollard R; Griffy KG; Wong R; Tarnowski TL; Casserella S; Jung D
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Mar; 17(3):227-34. PubMed ID: 9495222
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pilot study of zidovudine-lamivudine combination therapy in vertically HIV-infected antiretroviral-naive children.
    Horneff G; Adams O; Wahn V
    AIDS; 1998 Mar; 12(5):489-94. PubMed ID: 9543447
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical pharmacokinetics of lamivudine.
    Johnson MA; Moore KH; Yuen GJ; Bye A; Pakes GE
    Clin Pharmacokinet; 1999 Jan; 36(1):41-66. PubMed ID: 9989342
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Population pharmacokinetics of (R)-, (S)- and rac-methadone in methadone maintenance patients.
    Foster DJ; Somogyi AA; White JM; Bochner F
    Br J Clin Pharmacol; 2004 Jun; 57(6):742-55. PubMed ID: 15151520
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma population pharmacokinetics and penetration into cerebrospinal fluid of indinavir in combination with zidovudine and lamivudine in HIV-1-infected patients.
    Zhou XJ; Havlir DV; Richman DD; Acosta EP; Hirsch M; Collier AC; Tebas P; Sommadossi JP;
    AIDS; 2000 Dec; 14(18):2869-76. PubMed ID: 11153668
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Maintenance antiretroviral therapies in HIV-infected subjects with undetectable plasma HIV RNA after triple-drug therapy. AIDS Clinical Trials Group Study 343 Team.
    Havlir DV; Marschner IC; Hirsch MS; Collier AC; Tebas P; Bassett RL; Ioannidis JP; Holohan MK; Leavitt R; Boone G; Richman DD
    N Engl J Med; 1998 Oct; 339(18):1261-8. PubMed ID: 9791141
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiviral dynamics and sex differences of zidovudine and lamivudine triphosphate concentrations in HIV-infected individuals.
    Anderson PL; Kakuda TN; Kawle S; Fletcher CV
    AIDS; 2003 Oct; 17(15):2159-68. PubMed ID: 14523272
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of opioid dependence pharmacotherapies on zidovudine disposition.
    McCance-Katz EF; Rainey PM; Friedland G; Kosten TR; Jatlow P
    Am J Addict; 2001; 10(4):296-307. PubMed ID: 11783744
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Simultaneous vs sequential initiation of therapy with indinavir, zidovudine, and lamivudine for HIV-1 infection: 100-week follow-up.
    Gulick RM; Mellors JW; Havlir D; Eron JJ; Gonzalez C; McMahon D; Jonas L; Meibohm A; Holder D; Schleif WA; Condra JH; Emini EA; Isaacs R; Chodakewitz JA; Richman DD
    JAMA; 1998 Jul; 280(1):35-41. PubMed ID: 9660361
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of rilpivirine on the pharmacokinetics of methadone in HIV-negative volunteers.
    Crauwels HM; van Heeswijk RP; Vandevoorde A; Buelens A; Stevens M; Hoetelmans RM
    J Clin Pharmacol; 2014 Feb; 54(2):133-40. PubMed ID: 24203510
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune restoration in HIV-positive, antiretroviral-naive patients after 1 year of zidovudine/lamivudine plus nelfinavir or nevirapine.
    Plana M; Ferrer E; Martínez C; Podzamczer D; García F; Maleno MJ; Barceló JJ; García A; Barberá MJ; Lacarcel M; Miró JM; Gallart T; Gatell JM
    Antivir Ther; 2004 Apr; 9(2):197-204. PubMed ID: 15134181
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of co-formulated zidovudine, lamivudine and abacavir (Trizivir) on antiretroviral-naive patients presenting with advanced HIV-1 infection.
    Seaton RA; Fox R; Bodasing N; Peters SE; Gourlay Y
    AIDS; 2003 Feb; 17(3):445-7. PubMed ID: 12556701
    [No Abstract]   [Full Text] [Related]  

  • 40. Safety and efficacy of lamivudine-zidovudine combination therapy in antiretroviral-naive patients. A randomized controlled comparison with zidovudine monotherapy. Lamivudine European HIV Working Group.
    Katlama C; Ingrand D; Loveday C; Clumeck N; Mallolas J; Staszewski S; Johnson M; Hill AM; Pearce G; McDade H
    JAMA; 1996 Jul; 276(2):118-25. PubMed ID: 8656503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.